Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3

Sands Bruce E.; Van Assche Gert; Tudor David; Akhundova-Unadkat Gamar; Curtis Rebecca I.; Tan Tjoeke

首页> 外文期刊>Inflammatory bowel diseases >Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3

【24h】

Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3

机译：Vedolizumab与皮质类固醇组合在克罗恩病中的诱导治疗：双子座2和3的后HOC分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Combined therapy with vedolizumab and corticosteroids may improve clinical response or remission in Crohn's disease. The aim of this study is to assess efficacy and safety/tolerability of vedolizumab plus stable doses of corticosteroids at baseline during induction therapy in moderately to severely active Crohn's disease.

机译：背景：与vedolizumab和皮质类固醇的组合治疗可以改善克罗恩病的临床反应或缓解。本研究的目的是评估vedolizumab在诱导治疗期间在基线中评估vedolizumab加上皮质类固醇的疗效/可耐药性在诱导治疗中，以严重活跃的克罗恩病。

著录项

来源
《Inflammatory bowel diseases》 |2019年第8期|共8页
作者
Sands Bruce E.; Van Assche Gert; Tudor David; Akhundova-Unadkat Gamar; Curtis Rebecca I.; Tan Tjoeke;
展开▼
作者单位

Icahn Sch Med Mt Sinai Dr Henry D Janowitz Div Gastroenterol Annenberg Bldg Floor 5 1468 Madison;

Univ Leuven Leuven Belgium;

Takeda Pharmaceut Int AG Zurich Switzerland;

Takeda Pharmaceut Int AG Zurich Switzerland;

Takeda Int UK Branch London England;

Takeda Pharmaceut Int AG Zurich Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Crohn's disease; corticosteroids; vedolizumab; induction;

机译：克罗恩病;皮质类固醇;vedolizumab;诱导;

相似文献

外文文献
中文文献
专利

1. Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3 [J] . Sands Bruce E., Van Assche Gert, Tudor David, Inflammatory bowel diseases . 2019,第8期

机译：Vedolizumab与皮质类固醇组合在克罗恩病中的诱导治疗：双子座2和3的后HOC分析
2. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1 [J] . Reinisch Walter, Bressler Brian, Curtis Rebecca, Inflammatory bowel diseases . 2019,第4期

机译：在中度至重度溃疡性结肠炎中诱导诱导治疗后的粪便钙抗蛋白反应：双子座1的后HOC分析
3. Corrigendum to "Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6" [J Crohns Colitis 8S1 (2014) P497 S274-5] [J] . SandbornW.J., FeaganB., ReinischW., Journal of Crohn’s & colitis . 2014,第10期

机译：“在第6周对维多珠单抗诱导治疗无反应的克罗恩病患者继续接受维多珠单抗治疗的效果”更正[J Crohns结肠炎8S1（2014）P497 S274-5]
4. Why corticosteroids should not be used as first-line therapy for Crohn's disease [C] . J. M. RHODE Falk Symposium . 2006

机译：为什么皮质类固醇不应被用作克罗恩病的一线治疗
5. Yoga as an adjunctive therapy for Crohn's disease: A review of the effects of exercise and stress reduction on the quality of life and disease progression in Crohn's disease patients. [D] . Zuckerman, Julie. 2012

机译：瑜伽作为克罗恩氏病的辅助疗法：运动和减轻压力对克罗恩氏病患者生活质量和疾病进展的影响综述。
6. Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn’s Disease: A Post Hoc Analysis of GEMINI 2 and 3 [O] . Bruce E Sands, Gert Van Assche, David Tudor, -1

机译：Vedolizumab联合皮质类固醇用于克罗恩病的诱导治疗：对GEMINI 2和3的事后分析
7. >Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1 [O] . Edward V Loftus Jr, Bruce E Sands, Jean-Frédéric Colombel, 2020

机译：>在诱导治疗期间溃疡性结肠炎患者溃疡性结肠炎患者患者的持续无皮质类固醇临床缓解：Gemini 1 的后HOC分析

Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3

摘要

著录项

相似文献

相关主题

期刊订阅